Loading treatment…
Compounded — not FDA-approvedPrescription only
Compounded Liraglutide
Compounded — daily injection
An older GLP-1 medication taken as a once-daily injection rather than weekly, prescribed for medical weight loss when a provider judges it appropriate.
Compounded liraglutide is prepared for you by a licensed 503A compounding pharmacy and is not FDA-approved. It uses the active ingredient of Saxenda (liraglutide) but is not that product, and the FDA has not reviewed it for safety, effectiveness or quality. A provider may prescribe it only where they document a clinical reason it is right for you specifically.
From$369/mo$32 consultation included, not refunded · medication and shipping if prescribed
Choose your plan
4-week supply
Price
$369for a 4-week supply, if prescribed
Includes your $32 provider consultation (non-refundable). If your provider decides treatment isn’t appropriate, the medication portion is refunded automatically.
- Compounded semaglutide and tirzepatide are not prescribed in Ohio or Washington. A weight-loss visit there can still end in metformin, if prescribed — filled at a local pharmacy for pickup.
- Your provider confirms the dose. If they start you on a lower step, we refund the difference; if they choose a higher one within the same plan, the price you paid stands.
Adding to cart books a provider visit. You pay the shown total; the provider decides; the medication portion comes back automatically if they say no.
Questions
Will I definitely be prescribed this?
No — a consultation does not guarantee a prescription. Liraglutide is commercially available, including as a generic since 2025, so a compounding pharmacy may prepare it for you only where your prescriber documents a clinical reason the commercial product is not right for you specifically. If that reason isn't there, your provider will say so and the medication portion of your payment is refunded.
Why daily instead of weekly?
Because of how long the molecule lasts in the body: liraglutide acts for about a day, semaglutide and tirzepatide for about a week. Which rhythm suits you is a practical and clinical question for your provider, not a ranking.
Is liraglutide as effective as the weekly options?
Each has its own published trials, and we don't rank them on a marketing page. The liraglutide figure on this page comes from its own placebo-controlled trial; what it would mean for you depends on your history, and that is your provider's conversation.
How it works
Liraglutide is a GLP-1 receptor agonist: it resembles the gut hormone released after eating that signals fullness to the brain, slows stomach emptying and helps regulate insulin. Natural GLP-1 is cleared within minutes; liraglutide is built to bind to albumin in the blood and resist the enzyme that clears it, which stretches its action to around a day — hence the once-daily injection, where semaglutide's longer-lasting structure allows weekly dosing. The dose is stepped up weekly from a low start, and the appetite effect is the mechanism, not a side benefit. Whether a daily GLP-1 is the right fit for you is your provider's decision.
The full mechanismWhat the trials found
Published results, with what each was measured against.
These results come from trials of the FDA-approved product named in each citation. The compounded preparation on this page is not that product, was not studied in these trials, and has not been reviewed by the FDA for safety, effectiveness or quality.
7.4% mean body-weight change
vs 3.0% on placebo
Over 56 weeks at 3 mg daily alongside diet and activity counselling, in 3,731 adults with obesity, or overweight with a weight-related condition, and without diabetes — as reported in the current prescribing information.
Saxenda prescribing information, section 14, DailyMed, revised June 2026; Pi-Sunyer et al., SCALE Obesity and Prediabetes trial, New England Journal of Medicine, 2015
Trial averages describe a study population, not a prediction for you. Your provider will be direct about what is realistic given your history — and results depend on continuing treatment.
A provider may consider it if
- You and your provider prefer a daily rhythm — some people keep to a same-time-every-day injection more easily than a weekly one
- You've used liraglutide before and a provider judges that continuing it makes sense
- You're comfortable with a small daily injection and regular check-ins as the dose is stepped up
It won’t be prescribed if
- Anyone with a personal or family history of medullary thyroid carcinoma, or MEN 2 syndrome — this is a hard stop
- Pregnancy, trying to become pregnant, or breastfeeding
- A history of pancreatitis, without careful provider review
- Type 1 diabetes, gastroparesis, or an active eating disorder without in-person care
These are the same checks your provider runs in the visit. If one applies, they will tell you plainly — and the medication portion of what you paid comes back automatically.
What to expect
Week 1
A low starting dose injected once a day while your gut adapts. The approved product's schedule steps the dose up each week over about a month, and your provider follows a similar ramp.
Weeks 2–5
Weekly step-ups as tolerated. Nausea, if it comes, clusters around each increase and usually eases within days.
Ongoing
Reviewed at check-ins like any long-term treatment. Stopping generally means the appetite effect stops too — plan that with your provider.
Safety
Side effects, before you decide
Nausea, diarrhoea, constipation, vomiting, injection-site reactions and headache are the common ones, most often around dose increases. Serious but uncommon risks include pancreatitis, gallbladder disease, kidney injury from dehydration, and low blood sugar if you also take diabetes medication. The boxed warning covers thyroid C-cell tumours seen in rodents, which is why the MTC and MEN 2 history questions are a hard stop.
- Saxenda (liraglutide) prescribing information, DailyMed, revised June 2026 — boxed warning: thyroid C-cell tumours in rodents; contraindicated with a personal or family history of MTC or MEN 2
- Pi-Sunyer X, Astrup A, Fujioka K, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management (SCALE Obesity and Prediabetes). New England Journal of Medicine, 2015;373:11-22
Complete safety information is provided during your visit and with every prescription. This page is a summary, not a substitute for your provider's advice.
Also for weight loss
Compounded TirzepatideFrom$289/mo$32 consultation included, not refunded · medication and shipping if prescribed
Compounded SemaglutideFrom$169/mo$32 consultation included, not refunded · medication and shipping if prescribed
Compounded Sublingual SemaglutideFrom$179/mo$32 consultation included, not refunded · medication and shipping if prescribed
MetforminFrom$99$32 consultation included, not refunded · medication paid at your pharmacy, if prescribed
See whether compounded liraglutide is right for you.
A licensed provider reviews your visit and decides. You receive medication only if prescribed, and that portion of your payment is refunded automatically if they say no.